Moderna reposted this
START has officially dosed the first U.S. participant in Moderna’s Phase 1 clinical trial of mRNA-4106, a novel pan-tumor antigen therapy candidate for advanced solid tumors. https://lnkd.in/eN_w8Y6F This first-in-human study represents more than just a scientific milestone—it’s a demonstration of what’s possible when innovation meets access. The trial was initiated at START San Antonio, led by Dr. Amita Patnaik, MD, FRCPC, who shared, “mRNA represents a bold new frontier in cancer immunotherapy, and we’re proud to provide our patients access to this innovative treatment as part of a first-in-human trial.” Our CEO, Nick Slack, MBE, emphasized the impact of this moment: “This milestone reflects the core of who we are at START—accelerating the next generation of cancer therapies by bringing them directly to patients in the communities where they live.” We’re proud to partner with Moderna and contribute to advancing mRNA-based innovation in oncology. Learn more about the study: https://lnkd.in/eQE7-WJG #oncologyresearch #mRNA #clinicaltrials #oncology
Amazing news for all the cancer patients out there and confident that we will eventually see an end to the suffering.
Founder & CEO @ CytoCync | Helping Big Healthtech Teams Build Cool Software Without the Drama (or the Hidden Fees)
2w@The START Center for CancerThis is huge news! The first-in-human trial of mRNA-4106 marks a monumental step forward in cancer immunotherapy. It not only showcases the power of innovation but also underscores the importance of bringing cutting-edge treatments to where patients live and work. I love how this collaboration with Moderna exemplifies what’s possible when organizations come together to advance science for the greater good. It’s a reminder that progress isn’t just about theory—it’s about impact, accessibility, and transforming lives. Are there other areas in cancer research you believe hold similar promise? How can we amplify these efforts to benefit patients on a broader scale? Let’s discuss! 💡#CancerResearch #Innovation #PatientAccess Research